Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.

Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years ... “With such high expectations, there’s so much room for disappointment.” That was ...

From implementing AI to staffing shortage workarounds, here’s how ASC leaders and physicians are improving their practice’s workflow and efficiency. The more than 19 leaders featured below are ...

I feel terrified just looking at him.John on the other side of the phone said.When John said this, the situation was already very serious.Ye Chuan thought that Hare should still be in Johnson s room ...

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Eli Lilly shares are now positive for the year, up 10% since the start of January.